High medicine prices and poor affordability
Author:
- 1 July 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Psychiatry
- Vol. 24 (4) , 341-345
Abstract
In developing countries, most people who need medicines have to pay for them out of their own pockets. This review focuses on publications to explore the affordability gap of medicines and ways to close it. Cardiovascular medicines were unaffordable in low-income to middle-income countries, whereas dementia medicines were only affordable in regions of wealth. In urban Mozambique, local mark-ups are up to two-thirds of final price in private pharmacies, whereas some governments consistently paid higher prices above the international reference prices to procure a number of medicines. Generics competition from India made an originator brand manufacturer of a AIDS drug willing to supply the drug at a cheaper rate to poorer countries, whereas a Brazilian national program to produce nonprofit generics against protected patent of originator brand products to provide free AIDS drugs had cut the number of people dying by half and hospitalization by 80%, which saved about half a billion US dollars, making the program almost fund itself. Although lowering the manufacturer's price has a greater effect on the cost, policies to eliminate duties and taxes on medicines and regulate mark-ups are practical strategies to avoid excessive add-on costs.Keywords
This publication has 9 references indexed in Scilit:
- Quantifying the Impoverishing Effects of Purchasing Medicines: A Cross-Country Comparison of the Affordability of Medicines in the Developing WorldPLOS Medicine, 2010
- Adverse selection and the effect of health insurance on utilization of prescribed medicine among patients with chronic conditions2010
- International price comparisons of Alzheimer's drugs: a way to close the affordability gapInternational Psychogeriatrics, 2009
- Medicine prices in urban Mozambique: a public health and economic study of pharmaceutical markets and price determinants in low-income settingsHealth Policy and Planning, 2009
- Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysisThe Lancet, 2009
- Closing the Affordability Gap for Drugs in Low-Income CountriesNew England Journal of Medicine, 2007
- Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998Health Economics, 2003
- Differential pricing of essential drugsRevista Panamericana de Salud Pública, 2001
- The development of moral judgments concerning capital punishment.American Journal of Orthopsychiatry, 1975